X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
The slower pace of getting gene therapies to patients will most likely require the development of new standards and means of production. (Photo: Getty)

Despite the enormous promise of gene therapies, challenges in producing those therapies may put them out of reach of most American consumers at least in the near future, a new report said.

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.